New Jersey Transvaginal Mesh Litigations Schedule Case Management Conference for May 7th

New York, New York (PRWEB) April 03, 2015

The New Jersey Court overseeing thousands of transvaginal mesh lawsuits ( filed against C.R. Bard, Inc. and Ethicon, Inc. will convene the litigations next Case Management Conferences on May 7, 2015 at 12:00 p.m. Court records indicate that the proceedings will address the progress of product liability claims filed in Bergen County Superior Court on behalf of women who allegedly sustained serious vaginal mesh complications following the implantation of surgical mesh devices marketed by C.R. Bard and Ethicon. Bernstein Liebhard LLP Partner, Jeffrey S. Grand, is serving as Co-Liaison Counsel in both of the proceedings underway in Bergen County. (In re: Pelvic Mesh/Gynecare Litigation, No. 6341-10; In re: Pelvic Mesh Litigation/Bard, No. L-6339-10)

Our Firm is representing numerous women who have transvaginal mesh lawsuits pending in the New Jersey C.R. Bard and Ethicon litigations. We are looking forward to next months conference, where matters relevant to our clients cases will likely be discussed, says Sandy A. Liebhard, a partner at Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm continues to offer free legal consultations to alleged victims of serious vaginal mesh complications.

Nationwide Vaginal Mesh Litigations

Court documents indicate that more than 9,000 transvaginal mesh lawsuits are currently pending in the two multicounty litigations now underway in Bergen County Superior Court. This includes 1,730 cases filed in the C.R. Bard proceeding, and more than 7,700 claims included in the litigation involving Ethicon. All of the lawsuits similarly allege that the companies surgical mesh devices used to treat pelvic organ prolapse and stress urinary incontinence were defectively designed and manufactured, and put women at risk for mesh erosion, chronic pain, organ damage and other debilitating vaginal mesh complications. Plaintiffs further allege that C.R. Bard and Ethicon did not adequately test their devices before bringing them to market, and failed to provide patients and the medical community with sufficient warning regarding their risks.

In addition to his appointment as Co-Liaison Counsel for both New Jersey transvaginal mesh litigations, Mr. Grand also served on the Plaintiffs team during the first trial convened in the Ethicon proceeding. Court records indicate that the trial concluded in March 2013, with the jury awarding more than $ 11 million in compensatory and punitive damages to a woman who was injured by Ethicons Gynecare Prolift device. (Case No. Atl-L-6966-10)

Mr. Grand is also serving on the Plaintiffs Steering Committee in seven pelvic mesh litigations currently underway in the U.S. District Court, Southern District of West Virginia, including: In Re: American Medical Systems, Inc., Pelvic Repair Systems Products Liability Litigation – MDL No. 2325; In Re: Boston Scientific Corp., Pelvic Repair Systems Products Liability Litigation – MDL No. 2326; In Re: Coloplast Corp. Pelvic Support Systems Products Liability Litigation – MDL No. 2387; In Re: Cook Medical, Inc., Pelvic Repair System Products Liability Litigation – MDL No. 2440; In re: Ethicon, Inc. Pelvic Repair Systems Products Liability Litigation – MDL No. 2327; and In Re: Neomedic Pelvic Repair System Products Liability Litigation – MDL No. 2511.

Women who were allegedly harmed by transvaginal mesh may be eligible to receive compensation for medical bills, lost wages, pain and suffering and other damages. Find out more about transvaginal mesh complications by visiting Bernstein Liebhard LLP’s website or the firm’s Facebook page: To arrange for a free legal consultation, please call 800-511-5092.

About Bernstein Liebhard LLP

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $ 3 billion on behalf of our clients. The National Law Journal has recognized Bernstein Liebhard for twelve consecutive years as one of the top plaintiffs’ firms in the country. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP

10 East 40th Street

New York, New York 10016



Leave a Reply